๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Autoimmune hemolytic anemia associated with colon cancer

โœ Scribed by Akira B. Miura; Akira Shibata; Tetsuo Akihama; Yasuyuki Endo; Michiyoshi Sugawara; Iwao Ono; Tsutomu Watanuki

Publisher
John Wiley and Sons
Year
1974
Tongue
English
Weight
382 KB
Volume
33
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Hemolytic anemia associated with naproxe
Hemolytic anemia associated with naproxen
โœ J. A. Hughes; W. Sudell ๐Ÿ“‚ Article ๐Ÿ“… 1983 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 105 KB ๐Ÿ‘ 1 views
Hemolytic anemia associated with intrave
Hemolytic anemia associated with intravenous immunoglobulin
โœ John R. Wilson; Nirmala Bhoopalam; Morris Fisher ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 46 KB ๐Ÿ‘ 2 views

Intravenous immunoglobulin (IVIg) is a useful tool in the treatment of a variety of neuromuscular disorders. Though IVIg therapy is generally safe, hemolytic anemia is a potentially serious complication that is often overlooked, and is currently not listed in product inserts. We analyzed 45 patients

Rituximab therapy for chronic lymphocyti
Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia
โœ Giovanni D'Arena; Luca Laurenti; Silvana Capalbo; Alfonso Maria D'Arco; Rosaria ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 94 KB ๐Ÿ‘ 2 views

Autoimmune hemolytic anemia (AIHA) is a well-known complication of chronic lymphocytic leukemia (CLL). In recent years the anti-CD20 monoclonal antibody rituximab has been used for the therapy of steroid-refractory AIHA and autoimmune thrombocytopenia, either idiopathic or in association with CLL. W

Autoimmune hemolytic anemia in a patient
Autoimmune hemolytic anemia in a patient with idiopathic hypereosinophilia
โœ Massimo Arquati; Vincenzina Amodei; Paolo Foa; Alberto Tedeschi ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 136 KB ๐Ÿ‘ 2 views

changes in renal function. Proteinuria was reversible after withdrawal of the drug and was reproducible at reexposure. The extent of proteinuria was dose dependent. Renal biopsy revealed a (possibly pre-existing) minimal change glomerulonephritis. Uncovering of an underlying autoimmune defect by IFN